By Josh White
Date: Monday 27 Mar 2023
(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.
By Josh White
Date: Friday 20 Jan 2023
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.
By Josh White
Date: Tuesday 04 Oct 2022
(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.
Currency | UK Pounds |
Share Price | 3.13p |
Change Today | -0.18p |
% Change | -5.30 % |
52 Week High | 6.25 |
52 Week Low | 0.88 |
Volume | 576,496 |
Shares Issued | 4,766.44m |
Market Cap | £148.95m |
RiskGrade | 268 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:58 | 54,239 @ 3.05p |
15:26 | 12,500 @ 3.05p |
14:03 | 343 @ 3.24p |
14:00 | 2,500 @ 3.38p |
14:00 | 2,500 @ 3.38p |
You are here: research